Related Articles by Review for PMID: 30860767

Year	Number of Results
1998	1
1999	1
2000	1
2001	5
2002	2
2004	2
2006	1
2007	2
2008	1
2009	1
2011	1
2013	7
2014	4
2015	3
2016	1
2017	1
2018	6
2019	2
2020	4
2021	7
2022	2
2023	4
2024	1
2025	1

1

Wintheiser GA, Silberstein P. Wintheiser GA, et al. 2022 Sep 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2022 Sep 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30860767 Free Books & Documents.

2

Autoinhibitory mechanisms in receptor tyrosine kinases.

Hubbard SR. Hubbard SR. Front Biosci. 2002 Feb 1;7:d330-40. doi: 10.2741/A778. Front Biosci. 2002. PMID: 11815286 Review.

3

Cell-surface receptors transactivation mediated by g protein-coupled receptors.

Cattaneo F, Guerra G, Parisi M, De Marinis M, Tafuri D, Cinelli M, Ammendola R. Cattaneo F, et al. Int J Mol Sci. 2014 Oct 29;15(11):19700-28. doi: 10.3390/ijms151119700. Int J Mol Sci. 2014. PMID: 25356505 Free PMC article. Review.

4

Receptor tyrosine kinases: biological functions and anticancer targeted therapy.

Zhang N, Li Y. Zhang N, et al. MedComm (2020). 2023 Dec 7;4(6):e446. doi: 10.1002/mco2.446. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38077251 Free PMC article. Review.

5

Galectins as modulators of receptor tyrosine kinases signaling in health and disease.

Porębska N, Poźniak M, Matynia A, Żukowska D, Zakrzewska M, Otlewski J, Opaliński Ł. Porębska N, et al. Cytokine Growth Factor Rev. 2021 Aug;60:89-106. doi: 10.1016/j.cytogfr.2021.03.004. Epub 2021 Mar 27. Cytokine Growth Factor Rev. 2021. PMID: 33863623 Free article. Review.

6

Mechanisms of receptor tyrosine kinase activation in cancer.

Du Z, Lovly CM. Du Z, et al. Mol Cancer. 2018 Feb 19;17(1):58. doi: 10.1186/s12943-018-0782-4. Mol Cancer. 2018. PMID: 29455648 Free PMC article. Review.

7

Nuclear receptor tyrosine kinase transport and functions in cancer.

Chen MK, Hsu JL, Hung MC. Chen MK, et al. Adv Cancer Res. 2020;147:59-107. doi: 10.1016/bs.acr.2020.04.010. Epub 2020 Jun 13. Adv Cancer Res. 2020. PMID: 32593407 Review.

8

Mislocalisation of Activated Receptor Tyrosine Kinases - Challenges for Cancer Therapy.

Schmidt-Arras D, Böhmer FD. Schmidt-Arras D, et al. Trends Mol Med. 2020 Sep;26(9):833-847. doi: 10.1016/j.molmed.2020.06.002. Epub 2020 Jun 24. Trends Mol Med. 2020. PMID: 32593582 Review.

9

KIDs rule: regulatory phosphorylation of RTKs.

Locascio LE, Donoghue DJ. Locascio LE, et al. Trends Biochem Sci. 2013 Feb;38(2):75-84. doi: 10.1016/j.tibs.2012.12.001. Epub 2013 Jan 9. Trends Biochem Sci. 2013. PMID: 23312584 Review.

10

Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases.

Tang R, Langdon WY, Zhang J. Tang R, et al. Front Endocrinol (Lausanne). 2022 Jul 28;13:971162. doi: 10.3389/fendo.2022.971162. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35966060 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 30860767

56 results

Results by year